Investigation of the Efficacy of Algan Hemostatic Agent in Liver Laceration Model in Rats

Basit Öğe Kaydı
dc.contributor.authorMidi, Ahmet
dc.contributor.authorKumandaş, Ali
dc.contributor.authorEkici, Hüsamettin
dc.contributor.authorBayraktar, Feyzanur
dc.contributor.authorKarapirli, Kübra
dc.contributor.authorKarahan, Siyami
dc.contributor.authorÖzyürek, H. Emel
dc.date.accessioned2020-06-25T14:46:39Z
dc.date.available2020-06-25T14:46:39Z
dc.date.issued2019
dc.departmentKırıkkale Üniversitesi
dc.description.abstractObjectives: Bleeding control is crucial in preventing negative consequences by reducing blood loss in surgical operations. The aim of this study is to evaluate the hemostatic effect of a new herbal hemostatic agent called Algan Hemostatic Agent (AHA) in an uncontrolled bleeding model made by liver laceration.Methods: In these study 5–7 weeks-old 64 rats were used. Rats were randomly divided into 8 groups each consistingof eight rats (4 groups heparinize and 4 groups non-heparinize). The experimental liver laceration was performed, andphysiological serum impregnated gauze was applied to the control group for hemorrhage control, AHA liquid formimpregnated gauze, AHA gel, and AHA powder form were applied to experimental groups, respectively.Results: The shortest bleeding time was found in the AHA powder group. The AHA powder form stopped the bleedingin the heparinize group for a mean of 4 s, the non-heparinized group for 2 s. This was followed by the gel group and theliquid group. The bleeding time was significantly shorter in the all AHA group compared to the control group.Conclusion: This study showed that AHA is a highly effective hemostatic agent in controlling bleeding compared tothe control group.en_US
dc.identifier.citationMidi, A., Kumandaş, A., Ekici, H., Bayraktar, F., Karapirli, K., Karahan, S., Türk, M., Özyürek, H. E. (2019). Investigation of the Efficacy of Algan Hemostatic Agent in Liver Laceration Model in Rats. Eurasian Journal of Medicine and Oncology, 3(1), 37 - 42.en_US
dc.identifier.doi10.14744/ejmo.2018.0008
dc.identifier.endpage42en_US
dc.identifier.issn2587-2400
dc.identifier.issn2587-196X
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85094915440
dc.identifier.scopusqualityQ2
dc.identifier.startpage37en_US
dc.identifier.trdizinid333529
dc.identifier.urihttps://doi.org/10.14744/ejmo.2018.0008
dc.identifier.urihttps://app.trdizin.gov.tr/publication/paper/detail/TXpNek5USTVPUT09
dc.identifier.urihttps://hdl.handle.net/20.500.12587/1437
dc.identifier.volume3en_US
dc.identifier.wosWOS:000604245600007
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofEurasian Journal of Medicine and Oncology
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBiyolojien_US
dc.subjectAlerjien_US
dc.subjectAndrolojien_US
dc.subjectAnestezien_US
dc.subjectOdyoloji ve Konuşma-Dil Patolojisien_US
dc.subjectBiyokimya ve Moleküler Biyolojien_US
dc.subjectBiyofiziken_US
dc.subjectKalp ve Kalp Damar Sistemien_US
dc.subjectHücre Biyolojisien_US
dc.subjectKlinik Nörolojien_US
dc.subjectYoğun Bakım, Tıpen_US
dc.subjectDermatolojien_US
dc.subjectAcil Tıpen_US
dc.subjectEndokrinoloji ve Metabolizmaen_US
dc.subjectGastroenteroloji ve Hepatolojien_US
dc.subjectGeriatri ve Gerontolojien_US
dc.subjectSağlık Bilimleri ve Hizmetlerien_US
dc.subjectHematolojien_US
dc.subjectİmmünolojien_US
dc.subjectEnfeksiyon Hastalıklarıen_US
dc.subjectTamamlayıcı ve Entegre Tıpen_US
dc.subjectTıbbi Laboratuar Teknolojisien_US
dc.subjectGenel ve Dahili Tıpen_US
dc.subjectTıbbi Araştırmalar Deneyselen_US
dc.subjectMikrobiyolojien_US
dc.subjectNörolojik Bilimleren_US
dc.subjectKadın Hastalıkları ve Doğumen_US
dc.subjectOnkolojien_US
dc.subjectGöz Hastalıklarıen_US
dc.subjectOrtopedien_US
dc.subjectKulak, Burun, Boğazen_US
dc.subjectPatolojien_US
dc.subjectPediatrien_US
dc.subjectPeriferik Damar Hastalıklarıen_US
dc.subjectFizyolojien_US
dc.subjectTemel Sağlık Hizmetlerien_US
dc.subjectPsikiyatrien_US
dc.subjectHalk ve Çevre Sağlığıen_US
dc.subjectRadyoloji, Nükleer Tıp, Tıbbi Görüntülemeen_US
dc.subjectRehabilitasyonen_US
dc.subjectSolunum Sistemien_US
dc.subjectRomatolojien_US
dc.subjectSpor Bilimlerien_US
dc.subjectCerrahien_US
dc.subjectTransplantasyonen_US
dc.subjectTropik Tıpen_US
dc.subjectÜroloji ve Nefrolojien_US
dc.titleInvestigation of the Efficacy of Algan Hemostatic Agent in Liver Laceration Model in Ratsen_US
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
c1f78e39-b6cb-4d7c-b101-5df5a977945f.pdf
Boyut:
434.26 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/Full text
İndir

Koleksiyon

Makale Koleksiyonu
Makale Koleksiyonu
Makale Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu
WOS İndeksli Yayınlar Koleksiyonu